FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

THOUSAND OAKS Calif. July 11 2016 PRNewswire &160;Amgen NASDAQAMGN today announced that the U.S. Food and Drug Administration FDA has approved the Repatha&174; evolocumab Pushtronex&8482; system onbody infusor with prefilled cartridge a new mon...